<SEC-DOCUMENT>0001213900-20-024268-index.html : 20200828 <SEC-HEADER>0001213900-20-024268.hdr.sgml : 20200828 <ACCEPTANCE-DATETIME>20200828164811 ACCESSION NUMBER: 0001213900-20-024268 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20200828 DATE AS OF CHANGE: 20200828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-239928 FILM NUMBER: 201148454 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>ea126045-424b5_soligenixinc.htm <DESCRIPTION>PROSPECTUS SUPPLEMENT <TEXT> Document 1 - file: ea126045-424b5_soligenixinc.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: image_002.jpg
</DOCUMENT> </SEC-DOCUMENT>